Artificial Intelligence (AI) In Biopharmaceuticals Market to Reach $6.67 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Artificial Intelligence (AI) In Biopharmaceuticals Market?
The market size of artificial intelligence (AI) in biopharmaceuticals has seen substantial growth in recent times. The size is projected to rise from $1.59 billion in 2024 to $2.12 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 33.1%. The growth witnessed in the historical period is mainly due to developments in computational ability, growth in biomedical data, shifts towards precision medicine, and regulatory guidance and support.
What Growth Rate Is Forecasted for the Artificial Intelligence (AI) In Biopharmaceuticals Market by 2029?
In the coming years, the market size for artificial intelligence (AI) in biopharmaceuticals is projected to experience significant expansion. The market is forecasted to increase to $6.67 billion in 2029, with a compound annual growth rate (CAGR) of 33.2%. This upward trend during the predicted period can be credited to the progress in computational biology, the integration of multi-modal data, the synergy between AI and life sciences, favorable regulatory environments, and the adoption of ethical AI principles. Key trends for the forecast period embrace the incorporation of multi-omics data, the use of AI in drug creation and discovery, the understanding and acceptance of AI in regulatory circles, technological progress, regulatory advancements, and fresh emerging opportunities.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
Which Key Companies Are Shaping the Future of the Artificial Intelligence (AI) In Biopharmaceuticals Market?
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Which Factors Are Driving Demand in the Artificial Intelligence (AI) In Biopharmaceuticals Industry?
The escalating occurrence of persistent illnesses is projected to stimulate the development of artificial intelligence (AI) in the biopharmaceuticals market. Chronic illnesses are enduring conditions that typically advance gradually and can last for several years or even a lifetime. The triggers primarily include lifestyle habits, an elderly population, genetic factors, and environmental elements. AI used in biopharmaceuticals is progressively being employed to control chronic diseases since it is capable of analyzing vast quantities of varied data, pinpointing patterns, and customizing treatment strategies. A case in point, in November 2023, the Department of Health and Human Services, a US government department, reported an increase of 11 percent in new cases of chronic hepatitis B in 2022 compared to 2021. Hence, the escalating occurrence of chronic diseases is fueling the growth of artificial intelligence (AI) in the biopharmaceuticals market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
How Is the Artificial Intelligence (AI) In Biopharmaceuticals Market Segmented by Several Divisions?
The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
What are the Emerging Market Trends Driving the Growth of the Artificial Intelligence (AI) In Biopharmaceuticals Industry?
The primary focus for leading companies in the biopharmaceutical artificial intelligence (AI) industry is the creation of cutting-edge advancements such as the AI-powered solutions for target and lead identification suites. These are designed to expedite drug discovery processes and precision medicine, fundamentally reshaping life sciences organizations. These advancements, dedicated to drug discovery and precision medicine, provide an array of novel methodologies for developing new drugs and personalizing treatment plans. Google LLC, a US-based cloud computing service provider, launched two innovative AI-powered tools – the target and lead identification suites – in May 2023. These tools are designed to assist researchers in predicting and understanding protein structures, a fundamental aspect of drug creation. Additionally, this suite allows researchers to consume, stockpile, examine, and distribute vast amounts of genomic data, vital for precision medicine. These platforms intend to streamline drug discovery, cut down expenses, and expedite the delivery of new treatments to the market. By offering efficient data management, precise protein structure predictions, and progressive genomic analysis abilities, these tools aim to transform drug development processes and enhance patient outcomes.
Access The Full Report Here:
Which Regions Are Driving Growth in the Artificial Intelligence (AI) In Biopharmaceuticals Market?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251
This Report Delivers Insight On:
1. How big is the artificial intelligence (ai) in biopharmaceuticals market, and how is it changing globally?
2. Who are the major companies in the artificial intelligence (ai) in biopharmaceuticals market, and how are they performing?
3. What are the key opportunities and risks in the artificial intelligence (ai) in biopharmaceuticals market right now?
4. Which products or customer segments are growing the most in the artificial intelligence (ai) in biopharmaceuticals market?
5. What factors are helping or slowing down the growth of the artificial intelligence (ai) in biopharmaceuticals market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
